 | Andy Palmer
(Boston Area, MA, United States)
With a track record of 5 successful startups in the past 12 years, Andy is a specialist in accelerating the foundation & growth of early stage... |
 | Harry F. Hixson Jr.
male
Harry F. Hixson , Jr. , Ph.D. was Chairman of Discovery Partners International, Inc. prior to its merger with Infinity Pharmaceuticals |
 | Julian Adams
male
(Boston Area, ma, United States)
Julian Adams , Ph.D. Senior Vice President Research & Development, Infinity Pharmaceuticals |
 | Stuart L. Schreiber
male
Stuart Schreiber, Ph.D. Stuart Schreiber is the Morris Loeb Professor at Harvard University, where he is a member of the Department of Chemistry... |
 | Jeffrey K. Tong
male
Jeffrey K. Tong Vice President, Corporate and Product Development Jeffrey K. Tong , Ph.D., is the Vice President, Corporate and Product... |
 | Adelene Perkins , Vice Chair Chief Business Officer, Infinity Pharmaceuticals |
 | Jim Tananbaum
male
Jim Tananbaum is managing director and co-founder of Prospect Venture Partners II and III, a dedicated life science fund with over $1 billion in... |
 | Vicki L. Sato
female
Vicki L. Sato , Ph.D, is Professor of Management Practice at Harvard Business School, and also Professor of the Practice in the Department of... |
 | Mr. Rosenman joined the Company as Chief Financial Officer in June 2001. Prior to joining the Company, he was President and Chief Executive... |
 | Joshua Funder
male
Dr Joshua Funder joined GBS in 2004 with experience in biotechnology management, business strategy and the international pharmaceutical industry.... |
| |
